Murray Wong, MD
Adult Reconstructive Orthopaedic Surgery · Los Angeles, CANPI 1275243339
Payments from drug & device makers
What this record shows
This record is dominated by grants: $31,795 of the $49,263 with a category attached, or 64.5%. Smith+Nephew accounts for 84.6% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $26,592 and has fallen 62.4% since, to $10,000 in 2025.
Across 43 payments — averaging $1145.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$42K
- Zimmer Biomet$6K
- Medical Device Business Services, Inc.$332
- Linkbio Corp$186
- Stryker$175
- Biocomposites Inc$167
- plus $312 from 2 others
What the payments were for
- Grants$31,79565%
- Travel & lodging$4,6299%
- Food & beverage$2,8396%
- Education$10,00020%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 9 | $41,673 |
| Zimmer Biomet | 25 | $6,419 |
| Medical Device Business Services, Inc. | 4 | $332 |
| Linkbio Corp | 1 | $186 |
| Stryker | 1 | $175 |
| Biocomposites Inc | 1 | $167 |
| BD | 1 | $161 |
| My01 Inc. | 1 | $151 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Legion$1,577
- Avenir$1,479
- REAL INTELLIGENCE$1,353
- REDAPT$1,353
- Persona$847
- Arcos$702
- ROSA$373
- ACTIS$219
- MAKO$175
- Stimulan$167
- ARISTA AH FLEXITIP$161
- MY01 Continuous Compartmental Pressure Monitor$151
- OSS Orthopedic Salvage System$120
How this compares
$49,263 in reported general payments places this provider in the 70th percentile of 136 adult reconstructive orthopaedic surgery providers in California.
See all adult reconstructive orthopaedic surgery providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 50 | $1,062 |
| Oxycodone Hcl | 56 | $358 |
| Tramadol Hcl | 45 | $195 |
| Pantoprazole Sodium | 22 | $124 |
| Cephalexin | 18 | $119 |
| Ondansetron Hcl | 30 | $112 |
| Meloxicam | 22 | $81 |
| Amoxicillin | 25 | $21 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Los Angeles
- William LongLos Angeles$2.8M
- Nathanael HeckmannLos Angeles$722K
- Daniel OakesLos Angeles$296K
- Adam SassoonLos Angeles$274K
- William MaloneyStanford$11.1M
- James CaillouetteNewport Beach$4.8M
- John DearbornMenlo Park$2.5M
- William Bugbeela Jolla$2.1M
- James HuddlestonStanford$1.5M
- Alexander SahFremont$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.